Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,713 | 14,846 | 21,514 | 26,804 | 17,400 |
| TOTAL | $14,330 | $15,157 | $22,084 | $27,648 | $17,839 |
| Non-Current Assets | |||||
| PPE Net | 119 | 105 | 59 | 52 | 57 |
| Investments And Advances | 50 | 50 | 50 | 50 | 50 |
| Other Non-Current Assets | 391 | 391 | 391 | 391 | 391 |
| TOTAL | $560 | $546 | $500 | $493 | $498 |
| Total Assets | $14,889 | $15,702 | $22,585 | $28,141 | $18,337 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,814 | 4,122 | 5,266 | 6,386 | 4,650 |
| Other current liabilities | N/A | N/A | N/A | 7 | 16 |
| TOTAL | $6,063 | $4,122 | $5,266 | $6,393 | $4,666 |
| Non-Current Liabilities | |||||
| TOTAL | $13 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,077 | $4,122 | $5,266 | $6,393 | $4,666 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,967 | 3,853 | 3,678 | 3,674 | 3,670 |
| Common Shares | 116 | 111 | 111 | 110 | 80 |
| Retained earnings | -186,857 | -180,538 | -174,389 | -169,467 | -163,153 |
| TOTAL | $8,813 | $11,580 | $17,318 | $21,748 | $13,671 |
| Total Liabilities And Equity | $14,889 | $15,702 | $22,585 | $28,141 | $18,337 |